NCT02611752View on ClinicalTrials.gov

A Multiple Dose Opioid Challenge Study

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Moderate or Severe Opioid Use Disorder
Interventions
DRUG

CAM2038

CAM2038 subcutaneous injection

Trial Locations (3)

10032

New York Psychiatric Institute, New York

40513

University of Kentucky, Lexington

66212

Vince and Associates Clinical Research, Overland Park

Sponsors
All Listed Sponsors
lead

Braeburn Pharmaceuticals

INDUSTRY

NCT02611752 - A Multiple Dose Opioid Challenge Study | Biotech Hunter | Biotech Hunter